Viewing Study NCT00959933


Ignite Creation Date: 2025-12-25 @ 2:40 AM
Ignite Modification Date: 2025-12-27 @ 10:55 PM
Study NCT ID: NCT00959933
Status: COMPLETED
Last Update Posted: 2017-03-28
First Post: 2009-08-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Relative Bioavailability Study of Ribavirin 200 Capsules and Rebetol 200 mg Capsules in Females Under Non-Fasting Conditions
Sponsor: Sandoz
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module